Get started
Amgen Inc. 4.2% 22-FEB-2052Amgen Inc. 4.2% 22-FEB-2052Amgen Inc. 4.2% 22-FEB-2052
BondBondBond

Amgen Inc. 4.2% 22-FEB-2052

OverviewProfileNews
Full chart

Compare with Amgen Inc. 4.2% 22-FEB-2052



Key terms


Outstanding amount
‪881.72 M‬ USD
Face value
1,000.00 USD
Minimum denomination
2,000.00 USD
Coupon
4.20%
Coupon frequency
Semi-annual
Maturity date
Feb 22, 2052
Term to maturity
25 years

Bond info


Issuer
Amgen, Inc.
Sector
Health Technology
Industry
Biotechnology
Home page
amgen.com
Issue date
Feb 22, 2022
ISIN
US031162DF41
CUSIP
031162DF4
Identifiers
ISIN US031162DF41
CFI code
DTFNGR
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

Profile


Sign up to see advanced bond data
Unlock important bond data including coupon rates, redemption details, risk assessments, and much more.

News